Zileutin Articles
Cornerstone buys Critical Thera for $63M
19 May 2008
FDA investigates suicide link with Singulair
7 April 2008
SkyePharma's Zyflo CR debuts in USA
8 October 2007
SkyePharma's 6-month loss reduced 11%
1 October 2007
CyDex licenses Captisol for injectable zileuton
18 June 2007
SkyePharma and CTI submit reformulated zileuton to FDA
14 August 2006
CT's acne drug Zyflo fails in Ph II trial
25 July 2005
Critical Therapeutics submits sNDA to US FDA
11 April 2005
Skye's zileuton deal with Critical Thera
30 November 2003
Genset progress report, sees sales up 13.8%
23 July 1999
SkyePharma Benefits From Lilly Trial Advance
15 May 1998
CytoMed Commences CMI-977 Clinical Trials
14 May 1998
Genset Revenues More Than Double
30 April 1998
Vanguard Looks Back On Successful 1997
19 March 1998
Merck's Singulair Cleared In USA For Asthma
24 February 1998
Expanded Warnings For J&J's Hismanal
11 February 1998
1997: Another Good Year For New Chemical Entities
6 January 1998
Merck's Singulair Reaches The Market
5 January 1998
Second Approval For Merck's Singulair
4 September 1997
Merck's Singulair Shows Promise In Asthma
30 May 1997
First Launch Of Abbott's Zileuton, In USA
3 February 1997
SkyePharma and Abbott Licensing Deal
27 January 1997
US 4th Qtr/Year-End Results See Strong Growth
27 January 1997
Abbott's Zyflo Cleared For Asthma In USA
23 December 1996
Showing 1-28 of 28 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
